PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus - PubMed

PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus

G Condorelli et al. EMBO J. 1998.

Abstract

We have used differential display to identify genes whose expression is altered in type 2 diabetes thus contributing to its pathogenesis. One mRNA is overexpressed in fibroblasts from type 2 diabetics compared with non-diabetic individuals, as well as in skeletal muscle and adipose tissues, two major sites of insulin resistance in type 2 diabetes. The levels of the protein encoded by this mRNA are also elevated in type 2 diabetic tissues; thus, we named it PED for phosphoprotein enriched in diabetes. PED cloning shows that it encodes a 15 kDa phosphoprotein identical to the protein kinase C (PKC) substrate PEA-15. The PED gene maps on human chromosome 1q21-22. Transfection of PED/PEA-15 in differentiating L6 skeletal muscle cells increases the content of Glut1 transporters on the plasma membrane and inhibits insulin-stimulated glucose transport and cell-surface recruitment of Glut4, the major insulin-sensitive glucose transporter. These effects of PED overexpression are reversed by blocking PKC activity. Overexpression of the PED/PEA-15 gene may contribute to insulin resistance in glucose uptake in type 2 diabetes.

Similar articles

• Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells.

  Condorelli G, Vigliotta G, Trencia A, Maitan MA, Caruso M, Miele C, Oriente F, Santopietro S, Formisano P, Beguinot F. Condorelli G, et al. Diabetes. 2001 Jun;50(6):1244-52. doi: 10.2337/diabetes.50.6.1244. Diabetes. 2001. PMID: 11375323 Retracted.

• The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.

  Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, Lauro R, Sesti G. Hribal ML, et al. J Clin Endocrinol Metab. 2000 May;85(5):2004-13. doi: 10.1210/jcem.85.5.6608. J Clin Endocrinol Metab. 2000. PMID: 10843189

• Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells.

  Viparelli F, Cassese A, Doti N, Paturzo F, Marasco D, Dathan NA, Monti SM, Basile G, Ungaro P, Sabatella M, Miele C, Teperino R, Consiglio E, Pedone C, Beguinot F, Formisano P, Ruvo M. Viparelli F, et al. J Biol Chem. 2008 Aug 1;283(31):21769-78. doi: 10.1074/jbc.M803771200. Epub 2008 Jun 9. J Biol Chem. 2008. PMID: 18541525

• Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle.

  Ryder JW, Chibalin AV, Zierath JR. Ryder JW, et al. Acta Physiol Scand. 2001 Mar;171(3):249-57. doi: 10.1046/j.1365-201x.2001.00827.x. Acta Physiol Scand. 2001. PMID: 11412137 Review.

• Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism.

  Fiory F, Formisano P, Perruolo G, Beguinot F. Fiory F, et al. Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E592-601. doi: 10.1152/ajpendo.00228.2009. Epub 2009 Jun 16. Am J Physiol Endocrinol Metab. 2009. PMID: 19531639 Review.

Cited by

• Effect of SNPs in protein kinase C zeta gene on gene expression in the reporter gene detection system.

  Liu Z, Sun HX, Zhang YW, Li YF, Zuo J, Meng Y, Fang FD. Liu Z, et al. World J Gastroenterol. 2004 Aug 15;10(16):2357-60. doi: 10.3748/wjg.v10.i16.2357. World J Gastroenterol. 2004. PMID: 15285019 Free PMC article.

• PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer.

  Zanca C, Garofalo M, Quintavalle C, Romano G, Acunzo M, Ragno P, Montuori N, Incoronato M, Tornillo L, Baumhoer D, Briguori C, Terracciano L, Condorelli G. Zanca C, et al. J Cell Mol Med. 2008 Dec;12(6A):2416-26. doi: 10.1111/j.1582-4934.2008.00283.x. Epub 2008 Feb 15. J Cell Mol Med. 2008. PMID: 18284607 Free PMC article.

• ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.

  Wang S, Wang C, Hu Y, Li X, Jin S, Liu O, Gou R, Zhuang Y, Guo Q, Nie X, Zhu L, Liu J, Lin B. Wang S, et al. J Exp Clin Cancer Res. 2020 Nov 27;39(1):264. doi: 10.1186/s13046-020-01770-0. J Exp Clin Cancer Res. 2020. PMID: 33246486 Free PMC article.

• Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.

  Haling JR, Wang F, Ginsberg MH. Haling JR, et al. Mol Biol Cell. 2010 Feb 15;21(4):664-73. doi: 10.1091/mbc.e09-08-0659. Epub 2009 Dec 23. Mol Biol Cell. 2010. PMID: 20032303 Free PMC article.

• Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

  Song JH, Bellail A, Tse MC, Yong VW, Hao C. Song JH, et al. J Neurosci. 2006 Mar 22;26(12):3299-308. doi: 10.1523/JNEUROSCI.5572-05.2006. J Neurosci. 2006. PMID: 16554480 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal